Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Modafinil for narcolepsy

Article Abstract:

The FDA has approved modafinil for the treatment of narcolepsy. People with narcolepsy fall asleep at inappropriate times of the day. The drug, sold under the trade name Provigil in the US and Alertec in Canada, is a non-amphetamine stimulant. In clinical trials, it improved daytime alertness to between 50% and 70% of normal. However, long-term use leads to a loss of effectiveness. Although it may not be as effective as other stimulants, it has less potential for abuse.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 1999
Evaluation, Product/Service Evaluation, Provigil (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


New indications for Modafinil (Provigil)

Article Abstract:

In 1999 Modafinil has been approved for treatment of excessive daytime sleepiness associated with narcolepsy and now has also been approved for treatment of patients with excessive sleepiness due to obstructive sleep apnea/ hypopnea syndrome (OSAHS) or shift work sleep disorder (SWSD). It might cause some troublesome interactions with other drugs.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2004
Usage, Modafinil

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


An injectable hyaluronic acid (Restylane) for wrinkles

Article Abstract:

Hyaluronic acid (Restylane) that is manufactured by Q-Med AB has been approved by the FDA for correction of moderate to severe facial wrinkles and folds such as nasolabial folds. Injecting Restylane can produce good cosmetic results that may last about six months but local hypersensitivity reactions that are found, is reported.

Publisher: Medical Letter, Inc.
Publication Name: Medical Letter on Drugs and Therapeutics
Subject: Health
ISSN: 0025-732X
Year: 2004
United States, Biological Product (except Diagnostic) Manufacturing, Drugs, Hyaluronic Acid, Health aspects, Care and treatment, Powers and duties, United States. Food and Drug Administration, Skin aging

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy, Narcolepsy, Licensing, certification and accreditation
Similar abstracts:
  • Abstracts: New Options for the Treatment of Epilepsy. A comparison of rectal diazepam gel and placebo for acute repetitive seizures
  • Abstracts: Sildenafil: an oral drug for impotence. Antioxidant vitamins and zinc for macular degeneration. Sildenafil for pulmonary hypertension
  • Abstracts: Motility disorders. Anesthesia: safer than ever before. Chronic obstructive pulmonary disease
  • Abstracts: Access to dental care in Alabama for children with special needs. Early orthodontic treatment as a means to increase access for children enrolled in Medicaid in Washington state
  • Abstracts: Cover notes. White-knuckle ride to theatre. Evaluating the impact on patients of living with a leg ulcer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.